← Open Payments lookup

JEFFREY REINHART: Open Payments

NPI 1033105747 · MONTICELLO, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,131 in 46 payments from 16 companies in 2025. Trend: 2023 $1,334 · 2024 $1,227 · 2025 $1,131

Food & beverage: $1,131
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP7$234
ABBVIE INC.10$225
Novo Nordisk Inc3$132
Teva Pharmaceuticals USA, Inc.1$99
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$61
Lundbeck LLC3$49
Bayer Healthcare Pharmaceuticals Inc.3$47
PFIZER INC.3$47
Axsome Therapeutics, Inc.2$41
GlaxoSmithKline, LLC.2$41

Products named: VRAYLAR, LOKELMA, AUSTEDO XR, Ozempic, FARXIGA, UBRELVY, CAPLYTA, REXULTI.

Industry payments across AR — which companies pay providers there.